Pharmaceuticals, Biotechnology and Life Sciences
Akcea Therapeutics will be waiting August 2018, and expecting affirmation from FDA’s Metabolism and Endocrinology division for its treatment against…
The U.S. Food and Drug Administration has allowed of the first blood test to evaluate mild traumatic brain injury (mTBI),…
AstraZeneca and Merck will have a new Orphan Drug Designation in selumetinib, a MEK 1/2 inhibitor, as the US Food and…
This year’s Pharmapack Conference saw Bormioli Pharma, one of the world’s leading glass and plastic packaging manufacturers for the pharmaceutical sector, make a…
The U.S. Food and Drug Administration has approved Janssen Pharmaceutical ‘sErleada (apalutamide) for the treatment of patients with prostate cancer that has…
Celgene Corporation said that a higher proportion of patients taking apremilast 30 mg twice daily (BID) achieved clinical remission versus placebo.…
Celgene Corporation has authorized the repurchase of an additional $5 billion of its common stock. As the company noted, the…
Eli Lilly said on Tuesday that its Ankylosing Spondylitis treatment candidate, Taltz met the primary and all key secondary endpoints…
Vertex Pharmaceuticals Incorporated can now offer Symdeko for treating the underlying cause of cystic fibrosis (CF) for more certain patients.…
BD has received pre-market approval from the U.S. Food and Drug Administration for the BD Onclarity HPV assay, the company…